At eMyosound, we are redefining cardiac diagnostics with ultrasound precision. We are an innovative med-tech company dedicated to advancing cardiac healthcare through the development of non-invasive ultrasound elastography in the field of heart failure, HFpEF, amyloidosis, and overall cardiomyopathy.

Leveraging our founders’ 30 years of scientific expertise in cardiac ultrasound, biomechanics, and shear wave technologies, we strive to provide healthcare professionals with more precise and comprehensive tools for assessing myocardial/organ stiffness. Our commitment is to help improve patient management by exploring the potential of our technology. We aim to enhance the patient experience and inform clinical decisions, while upholding the highest standards of research and development.

Parallax Background

What We Offer

  • 1
    Non-invasive cardiac evaluation of the biomechanical properties of cardiac mechanics and function
  • 2
    Fast, scalable, cost-effective technology
  • 3
    Accurate and quantitative information about the heart’s biomechanical properties

Pioneering the Field of Cardiac Diagnostics

We are at the forefront of revolutionizing cardiac diagnostics through non-invasive ultrasound elastography.

Learn More About Us

See How Vocelo™ Quantifies Cardiac Insights

eMyosound harnesses advanced ultrasound technology to analyze cardiac tissue properties, providing insights into heart function and health through innovative, non-invasive, quantitative imaging techniques.

Discover Vocelo™

Background pattern topBackground pattern bottom

Let’s Connect

Newsletter is coming soon, enter your email to be the first to heard about us

Contact Us